Revenio Group Oyj · OMXHEX:REG1V
Revenio Group Oyj — Q3 2021 Earnings Presentation
11 slides from Revenio Group Oyj's earnings presentation, Oct 20, 2021
Slide 1: Q3/2021: An excellent quarter driven by very strong sales
JOUNI TOIJALA, CEO ROBIN PULKKINEN, CFO Q3/2021: AN EXCELLENT QUARTER DRIVEN BY VERY STRONG SALES Audiocast October 21 , 2021 st
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Revenio's shares. Revenio’s past performance is no guide to future performance, and persons needing advice should consult an independent financial adviser. This present
Slide 3: We aspire to keep the wonderful world visible for all
We aspire to keep the wonderful world visible for all Jouni Toijala Robin Pulkkinen CEO CFO
Slide 4: July – September 2021 highlights
July – September 2021 highlights An excellent quarter driven by very strong sales • Net sales were EUR 19.4 (15.8) million, up by 22.7% • Very strong growth in sales of fundus imaging devices in Europe and the United States. Tonometer demand continued to grow as well • Operating profit was EUR 5.9 (
Slide 5: Product update
Product update We improve the quality of clinical diagnostics with targeted product innovations New products are well received by the market: • iCare EIDON Ultra-Widefield fundus imaging device has been cleared for sales in all our key markets and initial customer demand has been strong • Sharp, hig
Slide 6: Q3: An excellent quarter driven by very strong sales
ROBIN PULKKINEN, CFO Q3: AN EXCELLENT QUARTER DRIVEN BY VERY STRONG SALES
Slide 7: Key figures, EUR million
Key figures, EUR million 7-9/2021 7-9/2020 Change, % 1–9/2021 1–9/2020 Change, % Net Sales 19.4 15.8 22.7 55.0 41.4 32.9% EBITDA 6.7 6.2 8.1% 17.2 13.4 28.1% EBITDA-% 34.7% 39.4% -4.7% 31.2% 32.4% -1.2% Adj EBITDA 6.7 6.2 8.1% 17.8 13.4 33.2% Adj EBITDA-% 34.7% 39.4% -4.7% 32.4% 32.4% 0,0% EBIT 5.9
Slide 8: Development of key figures
Development of key figures 100.0 % 84.0 % 81.8 % 78.9 % 80.0 % - Equity ratio has remained 59.5 % 64.0 % 60.0 % 53.2 % 58.6 % 60.9 % Equity ratio % strong 45.6 % 31.0 % 31.2 % 35.5 % 33.3 % 40.0 % 30.1 % 22.6 % 18.1 % 20.8 % 28.5 % - Oculo transaction the main Return on Investment % 20.0 % 11.2 % (a
Slide 9: Shareholders 30.9.2021
Shareholders 30.9.202 Owners REGIV Capital A Capital Verified 273,480 12.27% % + 1.40% 2021-09-30 1,231,259 % * + 0.15% 2021-09-30 REVENIO
Slide 10: Guidance
Guidance Financial guidance for 2021, updated on August 4, 2021 Revenio Group’s exchange rate adjusted net sales are estimated to grow very strongly from the previous year and profitability is to remain at a good level without non-recurring items. COVID-19 pandemic continues to cause uncertainty rel
Slide 11: We aspire to keep the wonderful world visible for all
“We aspire to keep the Financial guidance for 2021 – updated on August 4 , 2021 th wonderful world visible for all” Revenio Group’s exchange rate adjusted net sales are estimated to grow very strongly from the previous year and profitability is to remain at a good level without non-recurring items.